Delivery Order SPE2DR25D2207-SPE2DR26F0K02
- Not listed
- The Defense Logistics Agency awarded a $1,496.10 delivery order to AmerisourceBergen Drug Corp for Tobradex eye ointment (3.5 grams) under a firm fixed price contract. The order, with an ultimate completion date of October 27, 2025, was competitively awarded without any set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and serve as the prime contractor for this pharmaceutical supply delivery. This...
- The Defense Logistics Agency awarded a $1,857.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Tobradex eye ointment (3.5 grams) on September 5, 2025, with a completion date of September 8, 2025. This non-set-aside contract represents a small-value pharmaceutical delivery under the company's broader relationship with DLA Medical Supply Chain. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for Tobradex Eye Ointment (3.5gm) with a ceiling value of $1,639.13 under a firm fixed-price delivery order contract. This award is a non-set-aside, competitively awarded contract executed through the company's existing Indefinite Delivery Contract with DLA. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $2,478.27 to AmerisourceBergen Drug Corp for Tobradex Eye Ointment (3.5 GM) on October 27, 2025, with completion scheduled for October 28, 2025. This firm fixed price contract represents a non-set-aside award issued through competitive procurement, with performance to be executed at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,704.59 to AmerisourceBergen Drug Corp for Tobradex Eye Ointment 3.5GM on October 21, 2025, with an ultimate completion date of October 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under the company's broader relationship with the federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,581.72 to AmerisourceBergen Drug Corp for Tobradex eye ointment (3.5 grams) on July 14, 2025, with a completion date of July 15, 2025. This firm fixed-price delivery order was not set-aside and was competitively awarded. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order leverages...
- The Defense Logistics Agency awarded a delivery order valued at $1,082.34 to AmerisourceBergen Drug Corp for Tobradex Eye Ointment 3.5GM on September 23, 2025. This competitive award uses firm fixed pricing with no set-aside designation and is set for completion by September 24, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,509.39 to AmerisourceBergen Drug Corp for Tobradex eye ointment (3.5 grams) on July 24, 2025, with an ultimate completion date of July 25, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance will be executed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite...
- The Defense Logistics Agency awarded a $12,048.20 delivery order to AmerisourceBergen Drug Corp for Tobradex eye ointment (3.5 grams) on September 22, 2025, with a completion date of September 23, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $5,790.67 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Tobradex Eye Ointment (3.5 grams). This firm fixed-price contract, which closes on July 22, 2025, represents a single delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract is non-competitive and does not utilize a set-aside designation. Performance will occur at AmerisourceBergen's...
- SPE2DR25D2207Indefinite Delivery Contract
- SPE2DR25D2207-SPE2DR26F0K02Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,570.64 to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Tobradex Eye Ointment 3.5GM. This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 4, 2025, and performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company was competitively selected for its IDC based on demonstrated capability to supply a wide range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. This specific delivery order exemplifies the routine pharmaceutical fulfillment operations under the broader DLA prime vendor agreement, which enables flexible procurement of brand-name medications, generics, vaccines, and specialty medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 11/3/25 |